Use of glucagon-like peptide-1 (GLP-1) or analogs to abolish catabolic changes after surgery
A Standard patent application filed on 26 August 1997 credited to Efendic, Suad

Details

Application number :

40926  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of glucagon-like peptide-1 (GLP-1) or analogs to abolish catabolic changes after surgery  

Inventor :

Efendic, Suad  

Agent name :

Wrays  

Address for service :

Ground Floor 56 Ord Street WEST PERTH WA 6005  

Filing date :

26 August 1997  

Associated companies :

 

Applicant name :

Eli Lilly and Company  

Applicant address :

Lilly Corporate Center Indianapolis IN 46285 United States Of America  

Old name :

 

Original Source :

Go  

Same Inventor

• Use of GLP-1 or Analogs in Treatment of Stroke
• Use of GLP-1 or analogs in treatment of myocardial infarction
• Glucagon-like Peptides (GLP-1) and Treatment of Respiratory Distress
• Use of GLP-1 analogs and derivatives administered peripherally in...
• Use of a peptide